Capital Research Global Investors’s Qiagen QGEN Stock Holding History

Capital Research Global Investors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.74M	Buy	+119,998	New	+$5.68M	﹤0.01%	437
2018 Q3	–	Sell	-2,052,141	Closed	-$79.3M	–	462
2018 Q2	$79.3M	Buy	2,052,141 +168	+0%	+$6.18K	0.02%	306
2018 Q1	$70.3M	Hold	2,051,973	–	–	0.02%	320
2017 Q4	$67.9M	Hold	2,051,973	–	–	0.02%	312
2017 Q3	$68.5M	Hold	2,051,973	–	–	0.02%	315
2017 Q2	$72.4M	Hold	2,051,973	–	–	0.02%	313
2017 Q1	$63.2M	Hold	2,051,973	–	–	0.02%	317
2016 Q4	$63.4M	Buy	+2,051,973	New	+$61.1M	0.02%	319

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Research Global Investors's QGEN Position: Q1 2026 in Review

Capital Research Global Investors opened a new position in Qiagen (QGEN) in Q1 2026: 119,998 shares worth $4.74M. The stake represents ﹤0.01% of the portfolio and ranks #437 among its holdings. This is a return to the name: Capital Research Global Investors previously reported a position in QGEN as recently as Q2 2018.

Capital Research Global Investors first reported a position in QGEN in Q4 2016 and has held it in 8 quarters since. The position peaked at $79.3M in Q2 2018. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

Capital Research Global Investors held 119,998 shares of Qiagen worth $4.74M as of Q1 2026.
Qiagen was a new Capital Research Global Investors position in Q1 2026.
Qiagen made up ﹤0.01% of Capital Research Global Investors's portfolio in Q1 2026, its #437 holding.
Capital Research Global Investors first reported a position in Qiagen in Q4 2016 and has held it in 8 quarters since.
Capital Research Global Investors's Qiagen position peaked at $79.3M in Q2 2018.
344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.